<DOC>
	<DOCNO>NCT01071850</DOCNO>
	<brief_summary>Evaluate efficacy , safety , tolerability multiple dos ASP1941 compare placebo 12 week therapy adult patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>A Study Evaluate Effect ASP1941 Adult Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Subject diagnose type 2 diabetes Subject HbA1c value 6.8 9.5 % Subject never , currently take antidiabetic medication OR receive single anti diabetic agent lowdoses two antidiabetic medication willing discontinue study Subject stable diet exercise program Female subject pregnant agree use acceptable form contraception throughout duration study Subject type 1 diabetes mellitus Subject use insulin therapy Subject serum creatinine high upper limit normal Subject ALT and/or AST value high 3 time upper limit normal total bilirubin value 2 time upper limit normal Subject persistent , uncontrolled severe hypertension indicate systolic blood pressure &gt; 180 mmHg diastolic blood pressure &gt; 110mmHg Subject significant cardiovascular disease myocardial infarction vascular intervention ( e.g. , angioplasty stent ) last 3 month Subject know hepatitis carrier hepatitis B surface antigen , hepatitis C virus antibody know positive HIV1 and/or HIV2 Subject history lactic acidosis Subject history drug alcohol abuse/dependency within last 12 month Subject malignancy last 5 year , except successfully treat basal squamous cell carcinoma skin cervix Subject symptomatic urinary tract infection genital infection Female subject lactate Subject unstable medical psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>diabetes</keyword>
	<keyword>ASP1941</keyword>
	<keyword>Metformin</keyword>
</DOC>